New Resources:
Addressing Obesity through Holistic Design for Affordability and Sustainability
Florida Alliance for Healthcare Value Type 2 Diabetes Report – 9th edition
Thank you to our Affiliate Member Sanofi for their work in assembling this report.
Coverage of Anti-Obesity Medications – Webinar • August 24, 2023
Click HERE to view slide deck.
For information addressing the clinical questions asked during the webinar, click HERE.
Additional webinar resources:
Obesity in a Claims-Based Analysis of the Commercially Insured Population
Novo Nordisk A/S: Semaglutide 2/4 mg reduces the risk of major adverse cardiovascular events by 20% in adults with overweight or obesity in the SELECT trial
Weight Loss-Associated Decreases in Medical Care Expenditures for Commercially Insured Patients With Chronic Conditions
Thank you to our webinar sponsor:
New resources from Affiliate Member, Novo Nordisk:
Raise awareness around obesity – “Despite the millions of people living with obesity, this disease often gets overlooked by healthcare providers and leaves patients without the proper medical care they deserve. Obesity is about more than just excess weight, it’s about long-term health. People living with obesity are at a constant battle with their biology, where changes in their appetite hormone levels can cause them to gain back the weight, they’ve worked so hard to lose. Click here to learn more.”
The Weigh Forward – Recognize the Impact
The Economic Impact of Obesity on Your Organization
New resources from Affiliate Member, Sanofi:
Take Action When Diagnosed With Prediabetes or Type 2 Diabetes
Annual Out-of-Pocket Costs per All-Payer Type 2 Diabetes Patient Receiving Various Insulin and Non-Insulin Antidiabetic Therapies, 2021
Session #4 – July 13, 2022
Click here to view Session 4 slides that have been approved to share.
Additional Resources:
Florida Alliance Affiliate Member, Novo Nordisk, the sponsor of our final Diabetes ELC session featuring Jenny Goins of the Kentuckiana Health Collaborative, is keenly aware of the impact that obesity has on the health and mental wellbeing of your employees. To address the impacts of this chronic disease condition, Novo Nordisk has compiled vast and in-depth free resources on their website Novo Nordisk WORKSTM. Organizations can use the website to understand the value of chronic weight management, as well as help employees with their own health and wellness journey. Free resources span from the employer perspective to payers and formulary decision makers, and include helpful articles, data-driven research, customizable templates, learning modules for employees, and much more.
UPDATES:
Preventing Diabetes in Your Workforce by Incorporating a Proven Value-Based Benefits Design Strategy, the National Diabetes Prevention Program
Session #3 – June 28, 2022
Click here to view Session 3 slides.
Additional Resources:
Building Equity into Your Employee Health Benefit Design
Employer Health Equity Strategies
Improving Equity in Employee Health Benefits
McKinsey & Company 2021 Study – Income Alone May Be Inefficient: How Employers Can Help Advance Health Equity in the Workplace
Ignoring Inequitable Benefit Design is Not An Option
Dr. Bruce Sherman: Low Wage Workers Face Healthcare Headwinds (a 2-minute listen)
Prevent T2 For All
Prevent T2 For All (brochure)
Session #2 – June 7, 2022
Click here to view Session 2 slides.
Additional Resources:
Why Recognition Matters
Recognizing other names for the National Diabetes Prevention Program lifestyle change program
Session #1 – May 24, 2022
Click here to view Session 1 slides.
Additional Resources:
Florida Alliance for Healthcare Value Type 2 Diabetes Report – 8th edition
The New Science of Obesity – National Alliance of Healthcare Purchaser Coalitions Action Brief
